Drug Shortage Report for BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP

Last updated on 2018-05-31 History
Report ID 47197
Drug Identification Number 00037818
Brand name BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP
Common or Proper name Bacteriostatic Sodium Chloride
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 9MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 25x30mL PVL
ATC code B05CB
ATC description IRRIGATING SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-06-28
Actual start date
Estimated end date
Actual end date 2018-05-30
Shortage status Avoided shortage
Updated date 2018-05-31
Company comments 10mL and 20mL presentations remains available
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-04-25 English Compare
v2 2018-04-25 French Compare
v3 2018-05-31 English Compare
v4 2018-05-31 French Compare

Showing 1 to 4 of 4